These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 15787878)
1. Computer aided design mapping for SCORAD index in atopic dermatitis--accessible and economical. Kanthraj GR Pediatr Allergy Immunol; 2005 Mar; 16(2):182-3. PubMed ID: 15787878 [No Abstract] [Full Text] [Related]
2. Computer aided design mapping for SCORAD index in atopic dermatitis: ScoradCard software. Tripodi S Pediatr Allergy Immunol; 2005 Nov; 16(7):619. PubMed ID: 16238589 [No Abstract] [Full Text] [Related]
3. The objective severity assessment of atopic dermatitis (OSAAD) score: validity, reliability and sensitivity in adult patients with atopic dermatitis. Angelova-Fischer I; Bauer A; Hipler UC; Petrov I; Kazandjieva J; Bruckner T; Diepgen T; Tsankov N; Williams M; Fischer TW; Elsner P; Fluhr JW Br J Dermatol; 2005 Oct; 153(4):767-73. PubMed ID: 16181458 [TBL] [Abstract][Full Text] [Related]
4. Severity scoring of atopic dermatitis: a comparison of two scoring systems. Rullo VE; Segato A; Kirsh A; Sole D Allergol Immunopathol (Madr); 2008; 36(4):205-11. PubMed ID: 18928687 [TBL] [Abstract][Full Text] [Related]
5. Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score. Oranje AP; Glazenburg EJ; Wolkerstorfer A; de Waard-van der Spek FB Br J Dermatol; 2007 Oct; 157(4):645-8. PubMed ID: 17714568 [TBL] [Abstract][Full Text] [Related]
6. Patient-oriented SCORAD: a self-assessment score in atopic dermatitis. A preliminary feasibility study. Vourc'h-Jourdain M; Barbarot S; Taieb A; Diepgen T; Ambonati M; Durosier V; Sibaud V; Stalder JF Dermatology; 2009; 218(3):246-51. PubMed ID: 19147989 [TBL] [Abstract][Full Text] [Related]
7. The value of SCORAD and beyond. Towards a standardized evaluation of severity? Gelmetti C; Colonna C Allergy; 2004 Aug; 59 Suppl 78():61-5. PubMed ID: 15245360 [TBL] [Abstract][Full Text] [Related]
8. Measurement of body surface area in atopic dermatitis using specific PC software (ScoradCard). Tripodi S; Panetta V; Pelosi S; Pelosi U; Boner AL Pediatr Allergy Immunol; 2004 Feb; 15(1):89-92. PubMed ID: 14998388 [TBL] [Abstract][Full Text] [Related]
9. Objective evaluation for severity of atopic dermatitis by morphologic study of skin surface contours. Son SW; Park SY; Ha SH; Park GM; Kim MG; Moon JS; Yoo DS; Oh CH Skin Res Technol; 2005 Nov; 11(4):272-80. PubMed ID: 16221144 [TBL] [Abstract][Full Text] [Related]
10. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Kunz B; Oranje AP; Labrèze L; Stalder JF; Ring J; Taïeb A Dermatology; 1997; 195(1):10-9. PubMed ID: 9267730 [TBL] [Abstract][Full Text] [Related]
11. Reproducibility of severity rating for atopic dermatitis. Mazzotti E; Paradisi M; Provini A; Tabolli S Acta Derm Venereol; 2008; 88(1):60-1. PubMed ID: 18176754 [No Abstract] [Full Text] [Related]
12. Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults. Hon KL; Ching GK; Leung TF; Chow CM; Lee KK; Ng PC J Dermatolog Treat; 2009; 20(3):141-5. PubMed ID: 18951236 [TBL] [Abstract][Full Text] [Related]
13. Itch intensity evaluated in the German Atopic Dermatitis Intervention Study (GADIS): correlations with quality of life, coping behaviour and SCORAD severity in 823 children. Weisshaar E; Diepgen TL; Bruckner T; Fartasch M; Kupfer J; Lob-Corzilius T; Ring J; Scheewe S; Scheidt R; Schmid-Ott G; Schnopp C; Staab D; Szcepanski R; Werfel T; Wittenmeier M; Wahn U; Gieler U Acta Derm Venereol; 2008; 88(3):234-9. PubMed ID: 18480921 [TBL] [Abstract][Full Text] [Related]
14. Severity of disease, rather than xerosis, correlates with pruritus in patients with atopic dermatitis. Hachisuka J; Takeuchi S; Kido M; Fukiwake N; Furue M Int J Dermatol; 2009 Apr; 48(4):374-8. PubMed ID: 19335422 [TBL] [Abstract][Full Text] [Related]
15. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis. Nakazato J; Kishida M; Kuroiwa R; Fujiwara J; Shimoda M; Shinomiya N Pediatr Allergy Immunol; 2008 Nov; 19(7):605-13. PubMed ID: 18266834 [TBL] [Abstract][Full Text] [Related]
16. Ocular complications of atopic dermatitis in children. Carmi E; Defossez-Tribout C; Ganry O; Cene S; Tramier B; Milazzo S; Lok C Acta Derm Venereol; 2006; 86(6):515-7. PubMed ID: 17106598 [TBL] [Abstract][Full Text] [Related]
17. IgE antibody responses in young children with atopic dermatitis. Wahn U; Warner J; Simons FE; de Benedictis FM; Diepgen TL; Naspitz CK; de Longueville M; Bauchau V; Pediatr Allergy Immunol; 2008 Jun; 19(4):332-6. PubMed ID: 18422892 [TBL] [Abstract][Full Text] [Related]
18. Quantification of the extent and the severity of atopic dermatitis: the ADASI score. Bahmer FA; Schäfer J; Schubert HJ Arch Dermatol; 1991 Aug; 127(8):1239-40. PubMed ID: 1863088 [No Abstract] [Full Text] [Related]
19. The effect of dermatology consultations in secondary care on treatment outcome and quality of life in new adult patients with atopic dermatitis. Baron SE; Morris PK; Dye L; Fielding D; Goulden V Br J Dermatol; 2006 May; 154(5):942-9. PubMed ID: 16634899 [TBL] [Abstract][Full Text] [Related]
20. Serum mucosa-associated epithelial chemokine (MEC/CCL28) in atopic dermatitis: a specific marker for severity. Ezzat MH; Sallam MA; Shaheen KY Int J Dermatol; 2009 Aug; 48(8):822-9. PubMed ID: 19659860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]